Santhera Pharmaceuticals Provides Update on Royalty Agreement for AGAMREE (Vamorolone) and Warrants held by Idorsia
Pratteln, Switzerland, January 16, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces that…
Oculis Publishes Notification of Major Changes in Voting Rights
Accessibility: Skip TopNav January 03, 2025 18:48 ET | Source: Oculis Holding…
Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq
December 23, 2024 16:49 ET | Source: Neuphoria Therapeutics, Inc. BURLINGTON, Mass.,…